Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Celadon Pharmaceuticals PLC, a prominent UK-based company specializing in cannabis-based medicines, has distributed its 2023 Annual Report and information on the upcoming Annual General Meeting set for 27 June 2024. Shareholders can now access these documents on the company’s website. Celadon continues its focus on chronic pain and explores treatments for conditions like autism through its state-of-the-art EU-GMP approved UK facility.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
